Peter Whitton - 03 Mar 2022 Form 4 Insider Report for Bakhu Holdings, Corp.

Role: Director
Signature: Peter Whitton
Issuer symbol: BKUH on OTC
Transactions as of: 03 Mar 2022
Net transactions value: $0
Form type: 4
Filing time: 01 Jun 2022, 18:53:43 UTC
Previous filing: 25 Jan 2022
Next filing: 01 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BKUH	Common Stock	Gift	$0	+27,033,125	+21306%	$0.000000	27,160,007	03 Mar 2022	Direct
holding	BKUH	Common Stock						26,952,187	03 Mar 2022	Mentone Ltd.	F1
holding	BKUH	Series A Preferred Stock						4	03 Mar 2022	Cell Science Holding Ltd.	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	BKUH	Stock Option						100,000	03 Mar 2022	Common Stock	100,000	$5.10	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Mentone which is the owner of 26,952,187 shares, is owned 34% by Peter Whitton,33% by Geoffrey Dixon and 33% by Karl Watkin, and therefore each of Messrs. Whitton, Dixon and Watkin are deemed the owners of the 26,952,187 shares.
F2	Cell Science Holding Ltd., is the owner of 4 shares of Series A Preferred Stock. Cell Science is owned 40% by Inter-M Traders FZ LLE, 30% by the OZ Corporation, and 30% by Mentone Ltd., all of who are deemed to be the beneficial owners of the 4 shares of Series A Preferred Stock. Mr. Whitton is a 34% owner of Mentone thus would be deemed to be the beneficial owner of the 4 shares of Series A Preferred Stock, indirectly.

Content

Mentone which is the owner of 26,952,187 shares, is owned 34% by Peter Whitton,33% by Geoffrey Dixon and 33% by Karl Watkin, and therefore each of Messrs. Whitton, Dixon and Watkin are deemed the owners of the 26,952,187 shares.

Cell Science Holding Ltd., is the owner of 4 shares of Series A Preferred Stock. Cell Science is owned 40% by Inter-M Traders FZ LLE, 30% by the OZ Corporation, and 30% by Mentone Ltd., all of who are deemed to be the beneficial owners of the 4 shares of Series A Preferred Stock. Mr. Whitton is a 34% owner of Mentone thus would be deemed to be the beneficial owner of the 4 shares of Series A Preferred Stock, indirectly.